• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆三甲胺-N-氧化物及其前体与急性冠状动脉综合征患者心血管事件风险:肾功能的中介作用

Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.

作者信息

Sanchez-Gimenez Raul, Peiró Óscar M, Bonet Gil, Carrasquer Anna, Fragkiadakis Georgios A, Bulló Mònica, Papandreou Christopher, Bardaji Alfredo

机构信息

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.

Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

出版信息

Front Cardiovasc Med. 2022 Sep 21;9:1000815. doi: 10.3389/fcvm.2022.1000815. eCollection 2022.

DOI:10.3389/fcvm.2022.1000815
PMID:36211587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9532606/
Abstract

AIMS

To examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its precursors with risk of cardiovascular events in acute coronary syndrome (ACS), and determine whether these associations were mediated by renal function.

METHODS

In this prospective cohort study, we included 309 patients with ACS. During a mean follow-up of 6.7 years, 131 patients developed major adverse cardiovascular events (MACE) (myocardial infarction, hospitalization for heart failure, and all-cause mortality). Plasma concentrations of TMAO, trimethylamine (TMA), choline, betaine, dimethylglycine and L-carnitine were profiled by liquid chromatography tandem mass spectrometry. Hazard ratios were estimated with multivariable Cox regression models. The mediating role of estimated glomerular filtration rate (eGFR) was tested under a counterfactual framework.

RESULTS

After adjustment for traditional cardiovascular risk factors and medications, participants in the highest tertile vs. the lowest tertile of baseline TMAO and dimethylglycine concentrations had a higher risk of MACE [(HR: 1.83; 95% CI: 1.08, 3.09) and (HR: 2.26; 95% CI: 1.17, 3.99), respectively]. However, with regards to TMAO these associations were no longer significant, whereas for dimethylglycine, the associations were attenuated after additional adjustment for eGFR. eGFR mediated the associations of TMAO (58%) and dimethylglycine (32%) with MACE incidence. The associations between dimethylglycine and incident MACE were confirmed in an internal validation. No significant associations were found for TMA, choline, betaine and L-carnitine.

CONCLUSION

These findings suggest that renal function may be a key mediator in the association of plasma TMAO with the development of cardiovascular events after ACS. The present findings also support a role of dimethylglycine in the pathogenesis of MACE, which may be mediated, at least partially, by renal function.

摘要

目的

研究肠道微生物代谢产物氧化三甲胺(TMAO)及其前体与急性冠状动脉综合征(ACS)患者心血管事件风险的关联,并确定这些关联是否由肾功能介导。

方法

在这项前瞻性队列研究中,我们纳入了309例ACS患者。在平均6.7年的随访期间,131例患者发生了主要不良心血管事件(MACE)(心肌梗死、因心力衰竭住院和全因死亡)。通过液相色谱串联质谱法分析血浆中TMAO、三甲胺(TMA)、胆碱、甜菜碱、二甲基甘氨酸和左旋肉碱的浓度。采用多变量Cox回归模型估计风险比。在反事实框架下测试估计肾小球滤过率(eGFR)的中介作用。

结果

在调整传统心血管危险因素和药物后,基线TMAO和二甲基甘氨酸浓度处于最高三分位数组的参与者与最低三分位数组相比,发生MACE的风险更高[分别为(HR:1.83;95%CI:1.08,3.09)和(HR:2.26;95%CI:1.17,3.99)]。然而,就TMAO而言,这些关联不再显著,而对于二甲基甘氨酸,在进一步调整eGFR后,关联减弱。eGFR介导了TMAO(58%)和二甲基甘氨酸(32%)与MACE发生率的关联。二甲基甘氨酸与新发MACE之间的关联在内部验证中得到证实。未发现TMA、胆碱、甜菜碱和左旋肉碱有显著关联。

结论

这些发现表明,肾功能可能是血浆TMAO与ACS后心血管事件发生之间关联的关键中介因素。本研究结果还支持二甲基甘氨酸在MACE发病机制中的作用,这可能至少部分由肾功能介导。

相似文献

1
Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.血浆三甲胺-N-氧化物及其前体与急性冠状动脉综合征患者心血管事件风险:肾功能的中介作用
Front Cardiovasc Med. 2022 Sep 21;9:1000815. doi: 10.3389/fcvm.2022.1000815. eCollection 2022.
2
Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.社区老年人群中三甲基胺 N-氧化物的纵向血浆水平与动脉粥样硬化性心血管疾病事件的风险。
J Am Heart Assoc. 2021 Sep 7;10(17):e020646. doi: 10.1161/JAHA.120.020646. Epub 2021 Aug 16.
3
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.急性冠状动脉综合征中肠道微生物群依赖性三甲胺 N-氧化物:超越传统危险因素的心血管事件发生的预后标志物。
Eur Heart J. 2017 Mar 14;38(11):814-824. doi: 10.1093/eurheartj/ehw582.
4
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).肠道微生物群依赖性代谢产物氧化三甲胺(TMAO)与疑似功能性相关冠状动脉疾病(fCAD)患者的心血管风险
Clin Res Cardiol. 2022 Jun;111(6):692-704. doi: 10.1007/s00392-022-01992-6. Epub 2022 Feb 26.
5
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.胆碱和甜菜碱的预后价值取决于肠道微生物群产生的代谢物氧化三甲胺。
Eur Heart J. 2014 Apr;35(14):904-10. doi: 10.1093/eurheartj/ehu002. Epub 2014 Feb 3.
6
Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease.三甲胺 N-氧化物、胆碱及其代谢物与非酒精性脂肪性肝病的风险相关。
Br J Nutr. 2024 Jun 14;131(11):1915-1923. doi: 10.1017/S0007114524000631. Epub 2024 Mar 6.
7
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.胆碱代谢与 PREDIMED 研究中心律失常和心力衰竭的风险。
Clin Chem. 2021 Jan 8;67(1):288-297. doi: 10.1093/clinchem/hvaa224.
8
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.肾功能受损和代谢控制不佳会混淆三甲胺-N-氧化物的血浆水平。
Atherosclerosis. 2015 Dec;243(2):638-44. doi: 10.1016/j.atherosclerosis.2015.10.091. Epub 2015 Oct 24.
9
Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.三甲胺氮氧化物及其代谢物与老年人死亡率的关系。
JAMA Netw Open. 2022 May 2;5(5):e2213242. doi: 10.1001/jamanetworkopen.2022.13242.
10
Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.血浆中三甲胺 N-氧化物及相关代谢物与 2 型糖尿病发病风险的相关性:心血管健康研究。
JAMA Netw Open. 2021 Aug 2;4(8):e2122844. doi: 10.1001/jamanetworkopen.2021.22844.

引用本文的文献

1
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.急性缺血性卒中后用于风险分层的氧化三甲胺(TMAO):BIOSIGNAL队列研究结果
Eur Stroke J. 2025 Sep 7:23969873251366192. doi: 10.1177/23969873251366192.
2
Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis.肠道微生物代谢产物氧化三甲胺作为经皮冠状动脉介入治疗后不良心血管事件的新型预测指标:一项系统评价和剂量反应荟萃分析
Nutr J. 2025 Jun 16;24(1):91. doi: 10.1186/s12937-025-01159-9.
3
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons.解读肠道-器官轴中的氧化三甲胺:从生物标志物、细胞死亡机制到治疗前景
Drug Des Devel Ther. 2025 Apr 29;19:3363-3393. doi: 10.2147/DDDT.S512207. eCollection 2025.
4
Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities.微生物群衍生的氧化三甲胺(TMAO)作为心血管疾病中的多面生物标志物:挑战与机遇
Int J Mol Sci. 2024 Nov 21;25(23):12511. doi: 10.3390/ijms252312511.
5
Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease.肠道微生物群产生的低分子量化合物与心血管疾病。
Int J Mol Sci. 2024 Sep 27;25(19):10397. doi: 10.3390/ijms251910397.
6
Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis.肠道微生物代谢产物与主要不良心血管事件和死亡风险:系统评价和荟萃分析。
Medicine (Baltimore). 2024 May 31;103(22):e37825. doi: 10.1097/MD.0000000000037825.
7
Bile Acids and Risk of Adverse Cardiovascular Events and All-Cause Mortality in Patients with Acute Coronary Syndrome.胆汁酸与急性冠状动脉综合征患者不良心血管事件和全因死亡率的关系。
Nutrients. 2024 Apr 5;16(7):1062. doi: 10.3390/nu16071062.
8
TCA cycle metabolites associated with adverse outcomes after acute coronary syndrome: mediating effect of renal function.急性冠脉综合征后与不良结局相关的三羧酸循环代谢物:肾功能的中介作用
Front Cardiovasc Med. 2023 Jun 27;10:1157325. doi: 10.3389/fcvm.2023.1157325. eCollection 2023.
9
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?肠道微生物衍生的 TMAO:促进动脉粥样硬化性心血管疾病的因果因素?
Int J Mol Sci. 2023 Jan 18;24(3):1940. doi: 10.3390/ijms24031940.

本文引用的文献

1
Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies.肠道微生物衍生代谢物与心血管疾病风险:前瞻性队列研究的系统评价。
Nutrients. 2022 Jun 27;14(13):2654. doi: 10.3390/nu14132654.
2
Microbiome and metabolome features of the cardiometabolic disease spectrum.心血管代谢疾病谱的微生物组和代谢组特征。
Nat Med. 2022 Feb;28(2):303-314. doi: 10.1038/s41591-022-01688-4. Epub 2022 Feb 17.
3
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.胆碱代谢与 PREDIMED 研究中心律失常和心力衰竭的风险。
Clin Chem. 2021 Jan 8;67(1):288-297. doi: 10.1093/clinchem/hvaa224.
4
Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.肾功能与血浆三甲胺 N-氧化物、胆碱、左旋肉碱和甜菜碱有关:一项初步研究。
Int Urol Nephrol. 2021 Mar;53(3):539-551. doi: 10.1007/s11255-020-02632-6. Epub 2020 Sep 18.
5
Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications.急性冠状动脉综合征中的免疫与炎症:分子机制与治疗意义。
J Immunol Res. 2020 Aug 18;2020:4904217. doi: 10.1155/2020/4904217. eCollection 2020.
6
Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction.心力衰竭伴射血分数保留患者的血浆三甲胺 N-氧化物与肾功能相关。
BMC Cardiovasc Disord. 2020 Aug 28;20(1):394. doi: 10.1186/s12872-020-01669-w.
7
Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.三甲胺 N-氧化物在冠心病中有预后价值:一项荟萃分析和剂量反应分析。
BMC Cardiovasc Disord. 2020 Jan 9;20(1):7. doi: 10.1186/s12872-019-01310-5.
8
Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.慢性肾脏病中氧化三甲胺水平的升高:肾小球滤过率降低的贡献。
Toxins (Basel). 2019 Nov 1;11(11):635. doi: 10.3390/toxins11110635.
9
Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.慢性肾脏病患者的主要不良心血管事件与疾病严重程度和糖尿病状态有关。
PLoS One. 2019 Aug 28;14(8):e0221044. doi: 10.1371/journal.pone.0221044. eCollection 2019.
10
Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants.急性和稳定型冠状动脉疾病中氧化应激的新兴生物标志物:水平及决定因素
Antioxidants (Basel). 2019 May 1;8(5):115. doi: 10.3390/antiox8050115.